| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.047 | 0.8 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |